🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Ipca Laboratories Limited (BOM:524494)
India flag India · Delayed Price · Currency is INR
1,845.05
-14.70 (-0.79%)
At close: Nov 20, 2026

Ipca Laboratories Stock Forecast

Stock Price Forecast

According to 18 analysts polled by S&P Global, Ipca Laboratories stock has a consensus rating of "Buy" and an average price target of ₹2,098. The average 1-year stock price forecast is 13.72% higher than the current stock price, while the lowest is ₹1,731 (-6.18%) and the highest is ₹2,267 (+22.87%).

Price Target: ₹2,098 (+13.72%)
Analyst Consensus: Buy

Price Target

Chart
TargetLowAverageMedianHigh
Price₹1,731₹2,098₹2,153₹2,267
Change-6.18%+13.72%+16.66%+22.87%

Analyst Ratings

The average analyst rating for Ipca Laboratories stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Chart
RatingMay '26Jun '26Jul '26Aug '26Oct '26Nov '26
Strong Buy91010111110
Buy555444
Hold111223
Sell000000
Strong Sell111000
Total161717171717

Financial Forecast

Revenue This Year
111.05B
from 96.47B
Increased by 15.11%
Revenue Next Year
123.80B
from 111.05B
Increased by 11.48%
EPS This Year
59.84
from 46.94
Increased by 27.48%
EPS Next Year
71.25
from 59.84
Increased by 19.07%
Fiscal YearFY 2022FY 2023FY 2024FY 2025FY 2026FY 2027E
Period EndingMar 31, 2022Mar 31, 2023Mar 31, 2024Mar 31, 2025Mar 31, 2026Mar 31, 2027
Revenue
58.31B62.48B77.06B89.41B96.47B111.05B
Revenue Growth
7.56%7.16%23.33%16.03%7.90%15.11%
Gross Profit
36.23B37.25B48.58B58.60B64.86B78.81B
Gross Margin
62.13%59.62%63.05%65.54%67.23%70.97%
Operating Income
10.59B7.03B9.33B13.55B16.25B20.75B
Net Income
8.84B4.71B5.47B7.38B11.41B15.05B
EPS
----46.9459.84
EPS Growth
----33.58%27.48%
Forward PE
-----30.83
Dividend / Share
4.004.004.004.006.006.82
Dividend Growth
----50.00%13.67%
Free Cash Flow
----4.90B7.88B
No. Analysts
-----16
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is INR.

Revenue Forecast

Revenue202720282029
High113.3B
Avg111.0B
Low108.9B

Revenue Growth

Revenue Growth202720282029
High
17.5%
Avg
15.1%
Low
12.9%

EPS Forecast

EPS202720282029
High63.30
Avg59.84
Low55.10

EPS Growth

EPS Growth202720282029
High
34.9%
Avg
27.5%
Low
17.4%